Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor Cancer × PE regimen × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 4 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Solid Tumor Cancer 1 Progression Free Survival 1 Intracranial Germ Cell CNS Tumor, Childhood 1 Hormone Refractory Prostate Cancer 1 Carcinoma, Neuroendocrine 1 Carcinoma 1

Interventions

ispinesib 2 trametinib 1 irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡